Exome sequencing provides a deeper, more accurate view of your genetic makeup—delivering significantly higher diagnostic success than standard multigene panels or chromosomal microarray testing.
70% of genetic conditions surface during childhood, yet many families face a difficult, drawn-out path to answers:
Every day without a clear diagnosis is a missed opportunity. Early access to genetic answers can:
Leading medical organizations recommend exome sequencing as a first-line approach:
The American College of Medical Genetics and Genomics (ACMG) recommends exome or genome sequencing as a first-line test for individuals with developmental delays, intellectual disability, or congenital anomalies.
The National Society of Genetic Counselors, with endorsement from the American Epilepsy Society, advises exome or genome sequencing for all individuals with unexplained epilepsy.
Choosing exome testing from Precise Clinical Lab Care offers:
Double the diagnostic yield compared to chromosomal microarray
23% of patients receive a diagnosis they would have missed with standard multigene panels Streamlined testing for more effective, personalized care plans
Join hundreds of healthcare organizations that have improved patient outcomes and operational efficiency with Precisecare Lab.